CRA economists assisted Xiaomi in its global litigation against Sisvel, involving FRAND rate determination for cellular standard SEPs. CRA provided economic analysis support for Xiaomi in its litigation proceedings in China, Germany, Italy, and Netherlands, and expert reports were submitted in the Netherlands. The parties ultimately settled.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...